Skip to main content

Advertisement

SpringerLink
Log in

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

  • Editorial
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Third Department of Internal Medicine, Ehime University School of Medicine, Shitsukawa, Shigenobu-cho, Onsen-gun, Ehime 791-0295, Japan, , , , , , JP

    Norio Horiike & Morikazu Onji

Authors
  1. Norio Horiike
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Morikazu Onji
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Article on page 254 Immunological predictors of different responses to combination therapy with interferon α and ribavirin in patients with chronic hepatitis C Amaraa R, Mareckova H, Urbanek P, et al.

Reprint requests to: M. Onji

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horiike, N., Onji, M. Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C. J Gastroenterol 38, 302–304 (2003). https://doi.org/10.1007/s005350300054

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005350300054

Search

Navigation